Renal Impairment in Type 2 Diabetic Subjects

NCT00554450 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Dapagliflozin

Sponsor

AstraZeneca

Collaborators

[object Object]